NAM
BSX icon

NorthCrest Asset Manangement’s Boston Scientific BSX Stock Holding History

NorthCrest Asset Manangement’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$554K Buy
12,305
+4,269
+53% +$232K 0.01% 538
2026
Q1 		$505K Buy
+8,036
New +$643K 0.02% 472

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

NorthCrest Asset Manangement's BSX Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its Boston Scientific (BSX) stake by 53% in Q2 2026, buying an estimated $232K and bringing the position to 12,305 shares worth $554K. The position accounts for 0.01% of the portfolio, ranked #538.

NorthCrest Asset Manangement first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. 179 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • NorthCrest Asset Manangement held 12,305 shares of Boston Scientific worth $554K as of Q2 2026.
  • NorthCrest Asset Manangement bought 4,269 Boston Scientific shares in Q2 2026, an estimated $232K.
  • Boston Scientific made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #538 holding.
  • NorthCrest Asset Manangement first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • 179 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.